From 1 November 2023, Dr. Reiner Kern will be Director Communications and Public Affairs at DocMorris. In the newly created position, he is responsible for external and internal communications as well as political communications for the entire company. He reports to the CEO of DocMorris AG, Walter Hess.

Kern was head of communications at ABDA – Bundesvereinigung deutscher Apothekerverbände (Federal Association of German Pharmacists) – for eight years. Before that, the 57-year-old was head of the press and public relations department of the Kassenzahnärztliche Bundesvereinigung (KZBV) for ten years. He holds a doctorate in political science and was the office manager of a member of the Bundestag for eight years.

“Dr. Reiner Kern is very familiar with politics and the media landscape. With his many years of experience in the health care sector and especially in the pharmacy market, he is a proven industry expert”, says CEO Walter Hess. “The market is facing exciting times, especially in view of the mandatory introduction of e-prescriptions in Germany. We look forward to meeting these challenges together with Reiner Kern.”

Investors and analyst contact

Dr. Daniel Grigat, Head of Investor Relations & Sustainability

Email: ir@zurrose.com, phone: +41 58 810 11 49

Media contact

Torben Bonnke, Director Communications

EMail: media@zurrose.com, phone: +49 171 864 888 1

Agenda

DocMorris

The Swiss-based DocMorris AG is a leading company in the fields of online pharmacy, marketplace and professional healthcare with strong brands in Germany and other European countries. As Germany's largest online pharmacy, it operates DocMorris, the best-known health platform. Deliveries are mainly from the highly automated logistics centre in Heerlen, the Netherlands, with a capacity of over 27 million parcels per year. In Spain and France, the company operates the leading marketplace for health and personal care products in Southern Europe. With its business model, DocMorris offers its patients, customers and partners a broad range of products and services. In doing so, DocMorris is pursuing its vision of creating a digital health ecosystem for everyone to manage their health in one click. The company was renamed from Zur Rose Group AG to DocMorris AG in May 2023 after the Swiss business was sold to Migros/Medbase. Excluding the Swiss business, about 2,200 employees in Germany, the Netherlands, Spain, France and Switzerland generated an external revenue of CHF 1,159 million serving around 10 million active customers in 2022. The shares of DocMorris AG are listed on the SIX Swiss Exchange (securities number 4261528, ISIN CH0042615283, ticker DOCM). For further information, please visit corporate.docmorris.com.